These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8419206)

  • 1. Placental protein 14 secretion during in vitro fertilization cycles with and without human chorionic gonadotropin for luteal support.
    Anthony FW; Smith EM; Gadd SC; Masson GM; Chard T; Perry L
    Fertil Steril; 1993 Jan; 59(1):187-91. PubMed ID: 8419206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of serum and follicular fluid concentrations of placental protein 14 and CA-125 in in vitro fertilization-embryo transfer patients.
    Chryssikopoulos A; Mantzavinos T; Kanakas N; Karagouni E; Dotsika E; Zourlas PA
    Fertil Steril; 1996 Oct; 66(4):599-603. PubMed ID: 8816623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placental protein 14 in human in-vitro fertilization early pregnancies.
    Nylund L; Gustafson O; Lindblom B; Pousette A; Seppälä M; Riittinen L; Akerlöf E
    Hum Reprod; 1992 Jan; 7(1):128-30. PubMed ID: 1551949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the normal progesterone and placental protein 14 responses to human chorionic gonadotropin stimulation in the luteal phase.
    Batista MC; Cartledge TP; Nieman LK; Bravo N; Loriaux DL; Merriam GR
    Fertil Steril; 1994 Apr; 61(4):637-44. PubMed ID: 8150104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variations in concentrations of the major endometrial secretory proteins (placental protein 14 and insulin-like growth factor binding protein-1) in assisted conception regimes.
    Arthur ID; Anthony FW; Chard T; Masson GM; Thomas EJ
    Hum Reprod; 1995 Mar; 10(3):664-7. PubMed ID: 7540180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of prolactin secretion during ovarian hyperstimulation is followed by elevated serum levels of endometrial protein PP14 in the late luteal phase.
    Seppälä M; Martikainen H; Rönnberg L; Riittinen L; Kauppila A
    Hum Reprod; 1989 May; 4(4):389-91. PubMed ID: 2745669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The benefits of mid-luteal addition of human chorionic gonadotrophin in in-vitro fertilization using a down-regulation protocol and luteal support with progesterone.
    Herman A; Raziel A; Strassburger D; Soffer Y; Bukovsky I; Ron-El R
    Hum Reprod; 1996 Jul; 11(7):1552-7. PubMed ID: 8671503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical applications of serum placental protein 14 (PP14) measurement in the IVF-ET cycle.
    Suzuki Y; Sugiyama R; Fukumine N; Usuda S; Itoh H; Isaka K; Takayama M; Teisner B
    J Obstet Gynaecol Res; 2000 Aug; 26(4):295-302. PubMed ID: 11049241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective controlled study of luteal and endometrial abnormalities in an infertile population.
    Batista MC; Cartledge TP; Zellmer AW; Merino MJ; Nieman LK; Loriaux DL; Merriam GR
    Fertil Steril; 1996 Mar; 65(3):495-502. PubMed ID: 8774276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placental protein 14 and pregnancy-specific beta 1-glycoprotein in women with suppressed, normal and stimulated follicular maturation.
    Baumann CK; Bersinger NA; Birkhäuser MH
    Gynecol Endocrinol; 1998 Aug; 12(4):231-41. PubMed ID: 9798132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum progesterone levels in women treated with human menopausal gonadotropin and human chorionic gonadotropin for in vitro fertilization.
    Huang KE; Muechler EK; Schwarz KR; Goggin M; Graham MC
    Fertil Steril; 1986 Nov; 46(5):903-6. PubMed ID: 3096786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active corpus luteum function at pre-, peri- and postimplantation is essential for a viable pregnancy.
    Liu HC; Pyrgiotis E; Davis O; Rosenwaks Z
    Early Pregnancy; 1995 Dec; 1(4):281-7. PubMed ID: 9363260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Luteal-phase support in stimulated cycles in an in vitro fertilization/embryo transfer program: progesterone versus human chorionic gonadotropin.
    Nader S; Berkowitz AS; Ochs D; Held B; Winkel CA
    J In Vitro Fert Embryo Transf; 1988 Apr; 5(2):81-4. PubMed ID: 3411179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of low-dose human chorionic gonadotropin on corpus luteum function after embryo transfer.
    Mahadevan MM; Leader A; Taylor PJ
    J In Vitro Fert Embryo Transf; 1985 Dec; 2(4):190-4. PubMed ID: 4093702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone and human chorionic gonadotropin do not stimulate placental proteins 12 and 14 or prolactin production by human decidual tissue in vitro.
    Ren SG; Braunstein GD
    J Clin Endocrinol Metab; 1990 Apr; 70(4):983-9. PubMed ID: 2318953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes induced in serum protein profiles by ovarian stimulation during in-vitro fertilization--embryo transfer treatment: a comparison between conception and non-conception cycles.
    Yding Andersen C; Westergaard LG; Teisner B; Byskov AG; Ziebe S; Helledie L; Petersen K; Westergaard JG
    Hum Reprod; 1992 May; 7(5):585-91. PubMed ID: 1379264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daily low-dose hCG stimulation during the luteal phase combined with GnRHa triggered IVF cycles without exogenous progesterone: a proof of concept trial.
    Andersen CY; Elbaek HO; Alsbjerg B; Laursen RJ; Povlsen BB; Thomsen L; Humaidan P
    Hum Reprod; 2015 Oct; 30(10):2387-95. PubMed ID: 26209535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating concentrations of placenta protein 14 during the natural menstrual cycle in women significantly reflect endometrial receptivity to implantation and pregnancy during successive assisted reproduction cycles.
    Westergaard LG; Wiberg N; Andersen CY; Laursen SB; Kliem A; Westergaard JG; Teisner B
    Hum Reprod; 1998 Sep; 13(9):2612-9. PubMed ID: 9806294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of disruption versus continuation of gonadotrophin-releasing agonist after human chorionic gonadotrophin administration on corpus luteum function in patients undergoing ovulation induction for in-vitro fertilization.
    Valbuena D; Pellicer A; Guanes PP; Remohí J; Simón C
    Hum Reprod; 1997 Oct; 12(10):2118-22. PubMed ID: 9402265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum relaxin and the major endometrial secretory proteins in in-vitro fertilization and down-regulated hormone-supported and natural cycle frozen embryo transfer.
    Arthur ID; Anthony FW; Adams S; Thomas EJ
    Hum Reprod; 1996 Jan; 11(1):88-91. PubMed ID: 8671165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.